2.37
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRBU Giù?
Forum
Previsione
Precedente Chiudi:
$2.48
Aprire:
$2.54
Volume 24 ore:
2.09M
Relative Volume:
1.43
Capitalizzazione di mercato:
$220.42M
Reddito:
$34.48M
Utile/perdita netta:
$-102.07M
Rapporto P/E:
-1.6233
EPS:
-1.46
Flusso di cassa netto:
$-104.90M
1 W Prestazione:
+29.51%
1M Prestazione:
+68.09%
6M Prestazione:
+56.95%
1 anno Prestazione:
+4.87%
Caribou Biosciences Inc Stock (CRBU) Company Profile
Nome
Caribou Biosciences Inc
Settore
Industria
Telefono
510-982-6030
Indirizzo
2929 7TH STREET, SUITE 105, BERKELEY
Confronta CRBU con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
CRBU
Caribou Biosciences Inc
|
2.37 | 220.42M | 34.48M | -102.07M | -104.90M | -1.46 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-06-03 | Downgrade | Evercore ISI | Outperform → In-line |
2023-11-08 | Iniziato | Cantor Fitzgerald | Neutral |
2023-10-31 | Iniziato | Evercore ISI | Outperform |
2023-07-11 | Iniziato | Truist | Buy |
2022-02-18 | Iniziato | RBC Capital Mkts | Outperform |
2021-12-01 | Iniziato | Oppenheimer | Outperform |
2021-11-30 | Iniziato | H.C. Wainwright | Buy |
2021-11-15 | Aggiornamento | Citigroup | Neutral → Buy |
2021-08-17 | Iniziato | BofA Securities | Buy |
2021-08-17 | Iniziato | Citigroup | Neutral |
2021-08-17 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Caribou Biosciences Inc Borsa (CRBU) Ultime notizie
What analysts say about Caribou Biosciences Inc. stockTremendous financial leverage - Autocar Professional
What risks could impact Caribou Biosciences Inc. stock performanceUnprecedented growth rates - jammulinksnews.com
What drives Caribou Biosciences Inc. stock priceFree High-Return Strategy Alerts - Autocar Professional
Following a 1.3% Decline Over Last Year, Recent Gains May Please Caribou Biosciences, Inc. (NASDAQ:CRBU) Institutional Owners - 富途牛牛
Caribou Biosciences Inc. Stock Analysis and ForecastRapid wealth multiplication - jammulinksnews.com
Is Caribou Biosciences Inc. a good long term investmentDynamic profit opportunities - Autocar Professional
Why Caribou Biosciences Inc. stock is on top investor watchlistsFast Gains With Reduced Risk - Newser
Citi reiterates Buy rating on Caribou Biosciences stock ahead of key data By Investing.com - Investing.com South Africa
Citi reiterates Buy rating on Caribou Biosciences stock ahead of key data - Investing.com India
Caribou Biosciences: Key Data Updates Coming, But I'm Concerned About Near-Term Volatility - Seeking Alpha
Investors Can Still File Late Claims in Caribou Bioscience Settlement — Here’s How to Get Your Share - TradingView
Rachel Haurwitz - Forbes
Why Caribou Biosciences Inc. stock attracts strong analyst attentionRisk Adjusted Stock Signals - Newser
How Caribou Biosciences Inc. stock performs during market volatilityTriple Return With Stability - Newser
What makes Caribou Biosciences Inc. stock price move sharplyVerified Return Tips - Newser
Caribou Biosciences (CRBU) Soars 2.29% to 2025 High on FDA Clearance, Institutional Interest - AInvest
Caribou Biosciences(CRBU) soars 9.38% on FDA clearance, institutional interest - AInvest
Caribou Biosciences shares rise 1.88% in premarket after being listed as one of four stocks poised to ride the 2025 biotech growth wave. - AInvest
Biotech Sector Shows Promising Growth with Key Players Leading Innovation - citybuzz -
Caribou Biosciences (CRBU) Is Paying a $3.9M Settlement to Investors — Here’s How to Get Your Share - TradingView
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 24, 2025 in Caribou Biosciences, Inc. LawsuitCRBU - ACCESS Newswire
Caribou Biosciences Regains Nasdaq Compliance, Maintains Minimum Closing Bid Price - AInvest
Caribou Biosciences regains Nasdaq compliance with $1 minimum bid By Investing.com - Investing.com UK
FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering - Benzinga
Discovering RF Industries And 2 Other Promising Penny Stocks - simplywall.st
Caribou Biosciences Announces Director Elections and Auditor Confirmation - AInvest
Caribou Biosciences Confirms Director Elections and Auditor - TipRanks
Analysts Offer Predictions for CRBU FY2026 Earnings - Defense World
Caribou Biosciences (NASDAQ:CRBU) versus AlloVir (NASDAQ:ALVR) Critical Contrast - Defense World
Public Employees Retirement System of Ohio Takes $222,000 Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Nuveen Asset Management LLC Acquires 63,096 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionCRBU - ACCESS Newswire
Millennium Management LLC Has $1.37 Million Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU) - Defense World
Caribou Biosciences Inc Azioni (CRBU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):